Analyst Price Targets — LH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 8, 2026 1:14 pm | — | Evercore ISI | $300.00 | $274.72 | TheFly | Labcorp price target raised to $300 from $280 at Evercore ISI |
| February 24, 2026 11:40 am | David Westenberg | Piper Sandler | $300.00 | $285.30 | TheFly | Labcorp price target raised to $300 from $270 at Piper Sandler |
| February 18, 2026 12:48 pm | — | Robert W. Baird | $326.00 | $276.67 | TheFly | Labcorp price target raised to $326 from $313 at Baird |
| January 14, 2026 2:37 pm | — | Robert W. Baird | $313.00 | $259.18 | TheFly | Labcorp price target raised to $313 from $307 at Baird |
| October 29, 2025 12:55 pm | Kevin Caliendo | UBS | $320.00 | $253.74 | TheFly | Labcorp price target lowered to $320 from $325 at UBS |
| October 29, 2025 11:12 am | — | Robert W. Baird | $304.00 | $259.69 | TheFly | Labcorp price target lowered to $304 from $313 at Baird |
| October 28, 2025 5:09 pm | Michael Cherny | Leerink Partners | $342.00 | $261.63 | StreetInsider | Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted' |
| October 17, 2025 12:27 pm | — | UBS | $325.00 | $285.93 | TheFly | Labcorp price target raised to $325 from $305 at UBS |
| October 17, 2025 10:47 am | Ann Hynes | Mizuho Securities | $320.00 | $283.71 | TheFly | Labcorp price target raised to $320 from $285 at Mizuho |
| October 14, 2025 1:22 pm | — | Truist Financial | $320.00 | $278.42 | TheFly | Labcorp price target raised to $320 from $310 at Truist |
Latest News for LH
Birch Hill Investment Advisors LLC lessened its position in Labcorp Holdings Inc. (NYSE: LH) by 31.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 82,505 shares of the medical research company's stock after selling 37,071 shares during the period.
Assetmark Inc. raised its stake in shares of Labcorp Holdings Inc. (NYSE: LH) by 3.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 71,373 shares of the medical research company's stock after acquiring an additional 2,341 shares during the
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second counts Fentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics BURLINGTON, N.C., April 15, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Platform leverages agentic AI and diverse healthcare datasets to transform and speed drug development BURLINGTON, N.C., April 14, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.